Kader Sahin

7PUBLICATIONS
12CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 13, 2026
Structure-activity modeling and hybrid machine learning-based prediction of bioactivity in pyrazole derivatives for drug discovery applications.

Kader Şahin, Serhat Kiliçarslan, Serdar Durdaği

|May 13, 2024
Synthesis of Novel Hydrazide-Hydrazone Compounds and In Vitro and In Silico Investigation of Their Biological Activities against AChE, BChE, and hCA I and II.

Reşit Çakmak, Eyüp Başaran, Kader Sahin

|Nov 06, 2023
Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-Based Classifiers.

Safa Haddad, Lalehan Oktay, Ismail Erol

|Sep 16, 2021
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study.

Serdar Durdagi, Muge Didem Orhan, Busecan Aksoydan

|Jan 25, 2021
Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors.

Kader Şahİn, Serdar DurdaĞi

|Feb 15, 2020
A novel hybrid method named electron conformational genetic algorithm as a 4D QSAR investigation to calculate the biological activity of the tetrahydrodibenzazosines.

Kader Sahin, Emin Saripinar

Pageof 2

Frequent Collaborators

5 joint publications

Serdar Durdağı

2 joint publications

Emin Saripinar

1 joint publications

Mehmet Ay

1 joint publications

Muge Didem Orhan